Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hadji

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Breast (Edinburgh, Scotland)|November 21, 2007
Reducing the risk of bone loss associated with breast cancer treatmentP Hadji
Climacteric : the Journal of the International Menopause Society|December 25, 2010
Managing bone health with zoledronic acid: a review of randomized clinical study resultsP Hadji
Endocrine-Related Cancer|March 4, 2008
Menopausal symptoms and adjuvant therapy-associated adverse eventsP Hadji
Deutsche Medizinische Wochenschrift (1946)|April 26, 2003
[Possibilities and limitations of quantitative ultrasonometry in clinical practise]P Hadji
Climacteric : the Journal of the International Menopause Society|August 3, 2012
The evolution of selective estrogen receptor modulators in osteoporosis therapyP Hadji
Calcified Tissue International|December 4, 2001
Use of quantitative ultrasound densitometry (QUS) in male osteoporosisC Wüster, P Hadji
Climacteric : the Journal of the International Menopause Society|February 19, 2015
Calcium and bone health--goodbye, calcium supplements?A Ströhle, P Hadji, A Hahn
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|February 23, 2007
Clinical management of a pregnant patient with type I osteogenesis imperfecta using quantitative ultrasonometry--a case reportG Anderer, L Hellmeyer, P Hadji
Breast Cancer (Dove Medical Press)|December 25, 2013
Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancerM Bauer, J Bryce, P Hadji
Journal of Bone Oncology|June 24, 2016
Age-related differences in persistence with bisphosphonates in women with metastatic breast cancerL Jacob, P Hadji, K Kostev
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Breast (Edinburgh, Scotland)|November 21, 2007
Reducing the risk of bone loss associated with breast cancer treatmentP Hadji
Climacteric : the Journal of the International Menopause Society|December 25, 2010
Managing bone health with zoledronic acid: a review of randomized clinical study resultsP Hadji
Endocrine-Related Cancer|March 4, 2008
Menopausal symptoms and adjuvant therapy-associated adverse eventsP Hadji
Deutsche Medizinische Wochenschrift (1946)|April 26, 2003
[Possibilities and limitations of quantitative ultrasonometry in clinical practise]P Hadji
Climacteric : the Journal of the International Menopause Society|August 3, 2012
The evolution of selective estrogen receptor modulators in osteoporosis therapyP Hadji
Calcified Tissue International|December 4, 2001
Use of quantitative ultrasound densitometry (QUS) in male osteoporosisC Wüster, P Hadji
Climacteric : the Journal of the International Menopause Society|February 19, 2015
Calcium and bone health--goodbye, calcium supplements?A Ströhle, P Hadji, A Hahn
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|February 23, 2007
Clinical management of a pregnant patient with type I osteogenesis imperfecta using quantitative ultrasonometry--a case reportG Anderer, L Hellmeyer, P Hadji
Breast Cancer (Dove Medical Press)|December 25, 2013
Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancerM Bauer, J Bryce, P Hadji
Journal of Bone Oncology|June 24, 2016
Age-related differences in persistence with bisphosphonates in women with metastatic breast cancerL Jacob, P Hadji, K Kostev
Pageof 13